Publications dans lesquelles il/elle collabore avec JEZABEL RODRIGUEZ BLANCO (26)

2024

  1. Endoplasmic reticulum regulation of glucose metabolism in glioma stem cells

    International journal of oncology, Vol. 64, Núm. 1

  2. Mechanistic insights into medulloblastoma relapse

    Pharmacology and Therapeutics, Vol. 260

  3. Triptolide and its prodrug Minnelide target high-risk MYC-amplified medulloblastoma in preclinical models

    The Journal of clinical investigation, Vol. 134, Núm. 15

2022

  1. Noncanonical activation of GLI signaling in SOX2+ cells drives medulloblastoma relapse

    Science Advances, Vol. 8, Núm. 29

2021

  1. Regulation of cancer cell glucose metabolism is determinant for cancer cell fate after melatonin administration

    Journal of Cellular Physiology, Vol. 236, Núm. 1, pp. 27-40

2020

  1. Role of glucose metabolism in the differential antileukemic effect of melatonin on wild-type and FLT3-ITD mutant cells

    Oncology Reports, Vol. 44, Núm. 1, pp. 293-302

2017

  1. Inhibition of WNT signaling attenuates self-renewal of SHH-subgroup medulloblastoma

    Oncogene, Vol. 36, Núm. 45, pp. 6306-6314

2013

  1. Mechanisms involved in the pro-apoptotic effect of melatonin in cancer cells

    International Journal of Molecular Sciences, Vol. 14, Núm. 4, pp. 6597-6613

2012

  1. Cooperative action of JNK and AKT/mTOR in 1-methyl-4-phenylpyridinium-induced autophagy of neuronal PC12 cells

    Journal of Neuroscience Research, Vol. 90, Núm. 9, pp. 1850-1860

  2. Fas/Fas ligand regulation mediates cell death in human Ewing's sarcoma cells treated with melatonin

    British Journal of Cancer, Vol. 106, Núm. 7, pp. 1288-1296

2011

  1. Intracellular redox state as determinant for melatonin antiproliferative vs cytotoxic effects in cancer cells

    Free Radical Research, Vol. 45, Núm. 11-12, pp. 1333-1341

  2. Regulation of the expression of death receptors and their ligands by melatonin in haematological cancer cell lines and in leukaemia cells from patients

    Journal of Pineal Research, Vol. 50, Núm. 3, pp. 345-355

2010

  1. Melatonin sensitizes human malignant glioma cells against TRAIL-induced cell death

    Cancer Letters, Vol. 287, Núm. 2, pp. 216-223

  2. Synergistic antitumor effect of melatonin with several chemotherapeutic drugs on human Ewing sarcoma cancer cells: Potentiation of the extrinsic apoptotic pathway

    Journal of Pineal Research, Vol. 48, Núm. 1, pp. 72-80

2009

  1. Vías intracelulares implicadas en la muerte inducida por estrés oxidativo en neuronas dopaminergicas

    Vías intracelulares implicadas en la muerte inducida por estrés oxidativo en neuronas dopaminergicas

2008

  1. Intracellular signaling pathways involved in post-mitotic dopaminergic PC12 cell death induced by 6-hydroxydopamine

    Journal of Neurochemistry, Vol. 107, Núm. 1, pp. 127-140

2007

  1. Involvement of protein kinase C in melatonin's oncostatic effect in C6 glioma cells

    Journal of Pineal Research, Vol. 43, Núm. 3, pp. 239-244

  2. Melatonin prevents glutamate-induced oxytosis in the HT22 mouse hippocampal cell line through an antioxidant effect specifically targeting mitochondria

    Journal of Neurochemistry, Vol. 100, Núm. 3, pp. 736-746

  3. Signaling pathways involved in antioxidant control of glioma cell proliferation

    Free Radical Biology and Medicine, Vol. 42, Núm. 11, pp. 1715-1722

2006

  1. Intracellular signaling pathways involved in the cell growth inhibition of glioma cells by melatonin

    Cancer Research, Vol. 66, Núm. 2, pp. 1081-1088